rgx-121
Gene therapyexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Jul 31, 2018 (NCT03566043)
Timeline
Indications
Studied for
Mechanism of action
- Iduronate 2-sulfataseSUBSTRATE
IDS substrate
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07236606 | Phase 3 | Nov 25, 2025 | Regenxbio Inc. |
| NCT04571970 | Phase 1/Phase 2 (Phase 2) | Nov 30, 2020 | Regenxbio Inc. |
| NCT03566043 | Phase 1/Phase 2 (Phase 2) | Jul 31, 2018 | Regenxbio Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Regenxbio Inc. | For profit | 3 | 3 | 2 | 2018 |
1 organizations
Page 1 / 1